Polycystic ovarian syndrome: pregnancy outcome following in vitro fertilization-embryo transfer.

A retrospective study of a series of pregnant patients with polycystic ovarian syndrome following in vitro fertilization-embryo transfer was conducted to assess the outcome after ovarian stimulation by different protocols. Forty-one pregnancies were evaluated in patients with polycystic ovarian syndrome who conceived during in vitro fertilization-embryo transfer using human menopausal gonadotropin alone (17 pregnancies), or combined with gonadotropin releasing hormone analog (24 pregnancies). The demographic data of in vitro fertilization-embryo transfer cycles and pregnancy outcome were compared with the use of Student's t-test, the Mann-Whitney U test and Fisher's exact test, where appropriate. Among the pregnancies that were initiated following treatment, the protocol of the combination of the two was not associated with a higher rate of deliveries. The rate of first-trimester abortions was not statistically different between the two groups. These results suggest that the combined use of gonadotropin releasing hormone agonist and human menopausal gonadotropin in an in vitro fertilization program may not have beneficial effects on pregnancy outcome in patients with polycystic ovarian syndrome.

[1]  Z. Ben-Rafael,et al.  Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome. , 1993, Fertility and sterility.

[2]  B. Urman,et al.  The outcome of in vitro fertilization and embryo transfer in women with polycystic ovary syndrome failing to conceive after ovulation induction with exogenous gonadotropins. , 1992, Fertility and sterility.

[3]  J. Dor,et al.  The effect of gonadotropin-releasing hormone agonist on the ovarian response and in vitro fertilization results in polycystic ovarian syndrome: a prospective study. , 1992, Fertility and sterility.

[4]  S. Girit,et al.  Evaluation of tubal patency by transvaginal sonosalpingography. , 1992, Fertility and sterility.

[5]  T. Tanbo,et al.  In-vitro fertilization in infertile women with the polycystic ovarian syndrome. , 1991, Human reproduction.

[6]  E. Rudak,et al.  The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility. , 1990, Human reproduction.

[7]  J. Pearce,et al.  Recurrent spontaneous abortion and polycystic ovarian disease: comparison of two regimens to induce ovulation. , 1990, BMJ.

[8]  H. Burger,et al.  GnRH AGONIST ADMINISTRATION IN POLYCYSTIC OVARY SYNDROME , 1989, Clinical endocrinology.

[9]  R. Rosenfield,et al.  The polycystic ovary syndrome: pathogenesis and treatment. , 1989, Annals of internal medicine.

[10]  W. Dmowski,et al.  Successful use of gonadotropin-releasing hormone agonist leuprolide for in vitro fertilization in a patient with polycystic ovarian disease and infertility unresponsive to standard treatment. , 1988, Fertility and sterility.

[11]  A. Lanzone,et al.  Successful induction of ovulation and conception with combined gonadotropin-releasing hormone agonist plus highly purified follicle-stimulating hormone in patients with polycystic ovarian disease. , 1987, The Journal of clinical endocrinology and metabolism.

[12]  D. de Ziegler,et al.  Clinical and hormonal effects of chronic gonadotropin-releasing hormone agonist treatment in polycystic ovarian disease. , 1987, The Journal of clinical endocrinology and metabolism.

[13]  S. Pomerantz,et al.  8 Oocyte maturation inhibitor , 1986 .

[14]  G. Mccune,et al.  Successful treatment of infertile women with oligomenorrhoea using a combination of an LHRH agonist and exogenous gonadotrophins , 1985, British journal of obstetrics and gynaecology.

[15]  J. Yovich,et al.  Reduced in‐vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase , 1985, British journal of obstetrics and gynaecology.

[16]  R. Rolland,et al.  THE DYNAMICS OF PROLACTIN SECRETION DURING THE PUERPERIUM IN WOMEN , 1981, Clinical endocrinology.

[17]  J. Eppig.  The relationship between cumulus cell-oocyte coupling, oocyte meiotic maturation, and cumulus expansion. , 1982, Developmental biology.